• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将青蒿素重新用作与利福平协同作用的抗分枝杆菌药物。

Repurposing artemisinin as an anti-mycobacterial agent in synergy with rifampicin.

机构信息

Department of Chemical Engineering, Indian Institute of Technology Bombay, Mumbai, 400076, Maharashtra, India.

Department of Chemical Engineering, Indian Institute of Technology Bombay, Mumbai, 400076, Maharashtra, India; Wadhwani Research Center for Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, 400076, India.

出版信息

Tuberculosis (Edinb). 2019 Mar;115:146-153. doi: 10.1016/j.tube.2019.03.004. Epub 2019 Mar 14.

DOI:10.1016/j.tube.2019.03.004
PMID:30948170
Abstract

The current anti-TB treatment consists of a prolonged multi-drug therapy. Interventional strategies are required to reduce the chemotherapeutic load. In this regard, we have previously identified a synergistic interaction between hydroperoxides and rifampicin. This strategy has been extended here to repurpose a new drug against TB. A hydrophobic antimalarial drug, artemisinin, with an unstable endoperoxide bridge structure, has been investigated as a potential candidate. In combination with rifampicin, artemisinin was found to be synergistic against M. bovis BCG and M. tuberculosis H37Ra. Furthermore, artemisinin was observed to induce peroxides in a time and concentration dependent manner and the levels of the peroxides were significantly higher in cells treated with the drug pair. Coupled with rapid disintegration of the membrane, this enhanced the clearance of the bacterial culture in vitro. On the other hand, formation of the peroxides was significantly reduced in the presence of ascorbic acid, an antioxidant. This translated to a loss of the synergistic effect of the combination, indicating the importance of peroxide formation in the mode of action of artemisinin. Interestingly, artemisinin also had a synergistic interaction with isoniazid, amikacin and ethambutol and an additive interaction with moxifloxacin, other drugs commonly used against TB.

摘要

目前的抗结核治疗包括长期的多药物治疗。需要介入策略来降低化疗负荷。在这方面,我们之前已经确定了过氧化物和利福平之间的协同相互作用。这一策略在这里被扩展到重新利用一种新的抗结核药物。青蒿素是一种具有不稳定的内过氧化物桥结构的疏水抗疟药物,被认为是一种潜在的候选药物。研究发现,青蒿素与利福平联合使用对牛分枝杆菌 BCG 和结核分枝杆菌 H37Ra 具有协同作用。此外,青蒿素被观察到以时间和浓度依赖的方式诱导过氧化物,并且在用药物对处理的细胞中过氧化物的水平明显更高。与膜的快速崩解相结合,这增强了体外细菌培养物的清除。另一方面,在抗氧化剂抗坏血酸存在下,过氧化物的形成显著减少。这导致组合的协同作用丧失,表明过氧化物形成在青蒿素作用模式中的重要性。有趣的是,青蒿素还与异烟肼、阿米卡星和乙胺丁醇具有协同相互作用,与莫西沙星(一种常用于抗结核的药物)具有相加相互作用。

相似文献

1
Repurposing artemisinin as an anti-mycobacterial agent in synergy with rifampicin.将青蒿素重新用作与利福平协同作用的抗分枝杆菌药物。
Tuberculosis (Edinb). 2019 Mar;115:146-153. doi: 10.1016/j.tube.2019.03.004. Epub 2019 Mar 14.
2
The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.欧盟批准的抗疟药物咯萘啶显示出抗结核活性,并与利福平协同作用,作用靶点为RNA聚合酶。
Tuberculosis (Edinb). 2018 Sep;112:98-109. doi: 10.1016/j.tube.2018.08.004. Epub 2018 Aug 11.
3
Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin.合成阳离子α-螺旋肽的抗分枝杆菌活性及其与利福平的协同作用。
Biomaterials. 2014 Feb;35(6):2032-8. doi: 10.1016/j.biomaterials.2013.11.035. Epub 2013 Dec 4.
4
Enhancement of in vitro activity of tuberculosis drugs by addition of thioridazine is not reflected by improved in vivo therapeutic efficacy.添加硫利达嗪增强结核药物的体外活性,但并未在体内治疗效果改善中得到体现。
Tuberculosis (Edinb). 2014 Dec;94(6):701-7.
5
Vitamin C Potentiates the Killing of Mycobacterium tuberculosis by the First-Line Tuberculosis Drugs Isoniazid and Rifampin in Mice.维生素 C 增强一线抗结核药物异烟肼和利福平对小鼠结核分枝杆菌的杀伤作用。
Antimicrob Agents Chemother. 2018 Feb 23;62(3). doi: 10.1128/AAC.02165-17. Print 2018 Mar.
6
Synergistic interactions of SQ109, a new ethylene diamine, with front-line antitubercular drugs in vitro.新型乙二胺SQ109与一线抗结核药物在体外的协同相互作用。
J Antimicrob Chemother. 2006 Aug;58(2):332-7. doi: 10.1093/jac/dkl227. Epub 2006 Jun 3.
7
Considerations on the mechanism of action of artemisinin antimalarials: part 1--the 'carbon radical' and 'heme' hypotheses.青蒿素类抗疟药作用机制的思考:第1部分——“碳自由基”和“血红素”假说
Infect Disord Drug Targets. 2013 Aug;13(4):217-77. doi: 10.2174/1871526513666131129155708.
8
Activity of rifampicin and linezolid combination in Mycobacterium tuberculosis.利福平与利奈唑胺联合用药对结核分枝杆菌的活性
Tuberculosis (Edinb). 2017 May;104:24-29. doi: 10.1016/j.tube.2017.02.004. Epub 2017 Feb 20.
9
Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.一类新型异烟酰腙单独及与异烟肼、利福平、乙胺丁醇、对氨基水杨酸和氯法齐明联合使用对结核分枝杆菌的活性。
J Antimicrob Chemother. 2002 Feb;49(2):275-82. doi: 10.1093/jac/49.2.275.
10
In vitro chemotherapeutic combinations against isoniazid-resistant Mycobacterium tuberculosis and Mycobacterium fortuitum.针对耐异烟肼结核分枝杆菌和偶然分枝杆菌的体外化疗联合用药
Appl Microbiol. 1971 Sep;22(3):329-33. doi: 10.1128/am.22.3.329-333.1971.

引用本文的文献

1
Loss of glycerol catabolism confers carbon-source-dependent artemisinin resistance in .丧失甘油代谢导致. 对碳源依赖性青蒿素耐药。
Antimicrob Agents Chemother. 2024 Oct 8;68(10):e0064524. doi: 10.1128/aac.00645-24. Epub 2024 Aug 28.
2
Repurposing of anti-malarial drugs for the treatment of tuberculosis: realistic strategy or fanciful dead end?将抗疟药物重新用于治疗结核病:现实的策略还是不切实际的死胡同?
Malar J. 2024 May 3;23(1):132. doi: 10.1186/s12936-024-04967-2.
3
Tackling Nontuberculous Mycobacteria by Repurposable Drugs and Potential Leads from Natural Products.
利用可再利用药物和天然产物中的潜在先导化合物来应对非结核分枝杆菌。
Curr Top Med Chem. 2024;24(15):1291-1326. doi: 10.2174/0115680266276938240108060247.
4
Antibacterial and Antifungal Terpenes from the Medicinal Angiosperms of Asia and the Pacific: Haystacks and Gold Needles.亚洲和太平洋地区药用被子植物中的抗菌和抗真菌萜类化合物:干草堆和金针。
Molecules. 2023 May 4;28(9):3873. doi: 10.3390/molecules28093873.
5
Overcoming the Prokaryote/Eukaryote Barrier in Tuberculosis Treatment: A Prospect for the Repurposing and Use of Antiparasitic Drugs.克服结核病治疗中的原核生物/真核生物障碍:抗寄生虫药物重新利用和使用的前景。
Microorganisms. 2021 Nov 11;9(11):2335. doi: 10.3390/microorganisms9112335.
6
The Prospect of Repurposing Immunomodulatory Drugs for Adjunctive Chemotherapy against Tuberculosis: A Critical Review.将免疫调节药物重新用于辅助化疗治疗结核病的前景:批判性综述
Antibiotics (Basel). 2021 Jan 19;10(1):91. doi: 10.3390/antibiotics10010091.
7
Ethanol in Combination with Oxidative Stress Significantly Impacts Mycobacterial Physiology.乙醇与氧化应激的联合作用显著影响分枝杆菌的生理机能。
J Bacteriol. 2020 Nov 4;202(23). doi: 10.1128/JB.00222-20.
8
Artemisia annua and Artemisia afra extracts exhibit strong bactericidal activity against Mycobacterium tuberculosis.黄花蒿和青蒿提取物对结核分枝杆菌具有很强的杀菌活性。
J Ethnopharmacol. 2020 Nov 15;262:113191. doi: 10.1016/j.jep.2020.113191. Epub 2020 Jul 27.
9
Antiplasmodial Activity of -Substituted Benzyl Thiazinoquinone Derivatives and Their Potential against Parasitic Infections.取代苄基噻嗪并喹啉衍生物的抗疟原虫活性及其对寄生虫感染的潜在作用。
Molecules. 2020 Mar 27;25(7):1530. doi: 10.3390/molecules25071530.
10
Activation of artemisinin and heme degradation in Leishmania tarentolae promastigotes: A possible link.在利什曼原虫前鞭毛体中激活青蒿素和血红素降解:一种可能的联系。
Biochem Pharmacol. 2020 Mar;173:113737. doi: 10.1016/j.bcp.2019.113737. Epub 2019 Nov 29.